PUBLISHED: 22 NOVEMBER 2012
The view from the US: Stem cell therapy steps up a gear with first
approval and improved political climate
Special Report
Peter Winter
Positive clinical data, increases in federal funding and the first regulatory approval of a manufactured stem
cell product mean momentum is building in the US. With the re-election of President Obama, this is likely to
conf nue
Source: House Oversight Committee release, November 2025